The Chemours Company (NYSE:CC) Receives $28.22 Average Price Target from Brokerages

The Chemours Company (NYSE:CCGet Free Report) has been given a consensus rating of “Hold” by the eight brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $28.22.

Several research analysts have recently weighed in on the company. BMO Capital Markets downgraded Chemours from an “outperform” rating to an “underperform” rating and reduced their target price for the stock from $45.00 to $19.00 in a research note on Thursday, February 29th. UBS Group reiterated a “neutral” rating and set a $21.00 price target (down from $37.00) on shares of Chemours in a report on Tuesday, March 5th.

View Our Latest Analysis on CC

Chemours Price Performance

Shares of NYSE CC opened at $26.26 on Friday. The company has a quick ratio of 1.08, a current ratio of 1.54 and a debt-to-equity ratio of 5.40. Chemours has a 52 week low of $15.10 and a 52 week high of $39.05. The business’s 50 day moving average price is $27.96 and its 200 day moving average price is $28.04. The firm has a market cap of $3.91 billion, a P/E ratio of -16.94 and a beta of 1.97.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 3.81%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio is -64.52%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Hexagon Capital Partners LLC acquired a new stake in Chemours in the 4th quarter valued at about $25,000. Garner Asset Management Corp acquired a new position in shares of Chemours during the fourth quarter worth $29,000. Legacy Financial Group LLC acquired a new position in shares of Chemours during the third quarter worth $29,000. Morton Brown Family Wealth LLC acquired a new position in shares of Chemours during the fourth quarter worth $35,000. Finally, Neo Ivy Capital Management acquired a new position in Chemours in the fourth quarter valued at $40,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

About Chemours

(Get Free Report

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Stories

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.